Sophie Park

Grenoble, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Journal: Leukemia

Published: April 12, 2026

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Journal: Leukemia

Published: September 17, 2025

Flow cytometric lyophilised reagent tube assay for peripheral blood neutrophil myeloperoxidase expression to rule out myelodysplastic neoplasms at a university hospital: a diagnostic accuracy study.

Flow cytometric lyophilised reagent tube assay for peripheral blood neutrophil myeloperoxidase expression to rule out myelodysplastic neoplasms at a university hospital: a diagnostic accuracy study.

Journal: BMJ open

Published: August 22, 2025

Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.

Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.

Journal: Blood advances

Published: April 30, 2025

Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.

Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.

Journal: British journal of haematology

Published: March 28, 2025

Extended long-term follow-up and the survival of Stop Imatinib study.

Extended long-term follow-up and the survival of Stop Imatinib study.

Journal: Blood neoplasia

Published: February 10, 2025

IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

Journal: Blood

Published: November 04, 2024

MMS22L is a novel key actor of normal and pathological erythropoiesis.

MMS22L is a novel key actor of normal and pathological erythropoiesis.

Journal: HemaSphere

Published: November 04, 2024

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Journal: HemaSphere

Published: August 30, 2024

Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy study.

Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy study.

Journal: BMJ open

Published: June 18, 2024

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/ chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/ chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.

Journal: Haematologica

Published: June 06, 2024

Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents.

Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents.

Journal: Blood cancer journal

Published: May 24, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026